申请人:Syntex (U.S.A.) Inc.
公开号:US04912120A1
公开(公告)日:1990-03-27
The present invention is directed to certain 3,5 substituted, 4,5-dihydroisoxazoles, and methods for their use. These compounds are transgulatminase inhibitors, and are particularly effective in the inhibition of epidermal transglutaminase and the treatment of acne.
本发明涉及某些3,5-取代的4,5-二氢异噁唑烷衍生物,以及它们的使用方法。这些化合物是转谷氨酰胺酶抑制剂,特别有效于抑制表皮转谷氨酰胺酶并治疗痤疮。